Skip to main content
. Author manuscript; available in PMC: 2014 Feb 18.
Published in final edited form as: Thromb Res. 2012 Mar 8;129(0 2):S57–S61. doi: 10.1016/j.thromres.2012.02.035

Table 2.

ARFI-Monitored Hemostatic Challenge Bleeding Rates & Times to Hemostasis by Dog Phenotype.

Hemostasis Phenotype Dog Genotype n Mean Bleeding Rate (mm2/min) Mean Time to Hemostasis (min)*
Normal Hemostasis
    1. Normal 6 0.62 ± 0.33# 17.52 ± 6.05§
Abnormal Secondary Hemostasis
    2. Naïve Hemophilia A 8 0.86 ± 0.34# >30§
    3. Hemophilia A+FVIII to 11.3 ± 1.8% of normal 8 0.61 ± 0.30# 28.40 ± 12.39§
    4. Hemophilia A expressing FVIIa at 1.3 – 2 μg/ml [37] 3 0.62 ± 0.29# 26.09 ± 5.58§
Abnormal Primary Hemostasis
    5. Naïve VWD 6 1.72 ± 0.43# 23.98 ± 9.90§
    6. VWD+VWF to 7.1 ± 1.7% of normal VWF:Ag 4 0.47 ± 0.35# 14.64 ± 9.32§
*

ARFI Time to Hemostasis is defined as that required to bleed 75% of the total detected area of hemorrhage.

Mean from two separate procedures on each dog. No additional plasma therapy was required in these dogs.

#

Mean Bleeding Rate comparisons 1 vs 2 p<0.111, 1 vs 3 p<0.520, 1 vs 4 p<0.492, 1 vs 5 p<0.00003, 1 vs 6 p = 0.523, 5 vs 6 p = 0.00024.

§

Time to Hemostasis comparisons 1 vs 2 p<0.00078, 1 vs 3 p<0.027, 1 vs 4 p<0.057, 2 vs 4 p<0.01, 1 vs 5 p = 0.166, 1 vs 6 p = 0.566, 5 vs 6 p = 0.137.